Lucira Health rises on deal with Canadian co to sell COVID-19 test kits

Lucira Health

22/12/2021 13:40

** Shares of medical technology co  LHDX.O  up ~2% at $7.05
premarket
    ** Co announces agreement with Canada-based healthcare co,
Switch Health Solutions Inc, to increase Canadians' access to
at-home molecular COVID-19 tests  urn:newsml:reuters.com:*:nGNX6jbYFW 
    ** LHDX to provide more than 2 mln at-home COVID-19 test
kits next year, as part of the deal
    ** Last month, co said that its at-home, molecular test kits
can detect the new coronavirus Omicron variant  urn:newsml:reuters.com:*:nL4N2SK3D9 
    ** Up to Tuesday's close, stock had fallen ~72% since its
Feb. 5 debut 

 (Reporting by Oishee Majumdar in Bengaluru)
 ((oishee.majumdar@thomsonreuters.com;))